InkSpace Imaging, a company engaged with diagnostic medical device technology, has announced it received US Food and Drug Administration (FDA) clearance for its next-generation small body array for the Siemens Healthineers Magnetom Skyra and Vida series 3T magnetic resonance imaging (MRI) scanners.
This new medical device is part of their suite of MRI coils designed to revolutionise the patient experience while enhancing efficiency in MRI scans and clinical diagnosis.
As a recent press release states, the small body array is huggable, lightweight, and flexible. It wraps around patients like a blanket, ensuring unparalleled image quality. The body contouring design optimises the signal-to-noise ratio, which is crucial for detecting subtle abnormalities often missed by standard rigid, conventional coils. This leap in image quality means quicker and more accurate diagnoses, especially in complex cases.
InkSpace Imaging’s coils are up to 80% lighter and provide a 10–40% faster throughput. The design of the small body array is especially noteworthy for its flexibility which allows it to conform to a wide range of patient anatomies and sizes, significantly reducing scan times and minimising the duration patients need to remain still. This adaptability ensures all patients receive optimal imaging experiences, enhanced patient comfort, and significantly benefits technologists by streamlining the imaging process due to its high coil element density.
Peter Fischer, CEO of InkSpace Imaging, stated: “The FDA clearance of InkSpace Imaging’s small body array marks a pivotal moment in MRI technology advancement. Our suite of MR coils is a game-changer, offering total freedom in coil positioning and handling. What’s truly impressive is how our thin flexible coil contours to each patient’s body, offering comfort while enhancing image quality. It’s a win-win for patients and healthcare providers alike.”
